P
Passage Bio, Inc. (PASG)
6.38
0.00 (0.00%)

6.38
0.00 (0.00%)
This stock has a consensus price target of $17.67 based on the ratings of 6 analysts. The high is $40.00 and the low is $5.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 5 | $ 17.67 | $ 40 |
| O’zgarish | -21.63% | 176.96% | 526.96% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-04 | 260.5% | Canaccord Genuity | $67 → $23 | Maintains | Buy |
| 2025-11-12 | 229.15% | Chardan Capital | $6 → $21 | Maintains | Buy |
| 2025-08-14 | 950.16% | Canaccord Genuity | $260 → $67 | Maintains | Buy |
| 2025-08-14 | 56.74% | Guggenheim | $40 → $10 | Maintains | Buy |
| 2025-08-13 | 526.96% | Wedbush | $3 → $40 | Maintains | Outperform |